Optical transillumination spectroscopy to quantify parenchymal tissue density: an indicator for breast cancer risk.

Mammographic screening for early detection of breast cancer has proven valuable in improving breast cancer survival. However, breast cancer incidence is still increasing, and thus preventative oncology needs to receive more attention, with the goal of identifying women with increased risk of developing breast cancer in the future and offering them risk reduction interventions. Mammogram derived parenchymal density pattern has been shown by various authors to provide a high odds ratio for breast cancer. Near-infrared optical transillumination spectroscopy was employed to determine physiological properties of the breast tissue to quantify differences in women with low or high breast cancer risk. Specifically in this study, women who had a recent mammogram underwent examination of their breast tissue by optical transillumination spectroscopy. Areas of adipose and glandular tissues which give rise to mammographic density patterns also have characteristic optical transillumination spectra. Correlation between optical transillumination spectroscopy and mammographic density pattern was established using partial least squares analysis. Results show that predicted tissue density based on optical transillumination spectroscopy correlates with mammographic observed tissue density, with a Spearman Rank correlation coefficient of 0.72. This suggests that optical transillumination spectroscopy may be a promising tool to quantify and monitor changes in breast cancer risk.

[1]  J. Wolfe,et al.  Mammographic features and breast cancer risk: effects with time, age, and menopause status. , 1995, Journal of the National Cancer Institute.

[2]  M. Ferrari,et al.  Identification and Quantification of Intrinsic Optical Contrast for Near‐infrared Mammography , 1998, Photochemistry and photobiology.

[3]  S. Taplin,et al.  Reproductive and hormonal factors associated with mammographic breast density by age (United States) , 2000, Cancer Causes & Control.

[4]  L. Bernstein,et al.  Exercise activity, body size and premenopausal breast cancer survival , 2004, British Journal of Cancer.

[5]  M J Yaffe,et al.  Thickness-equalization processing for mammographic images. , 1997, Radiology.

[6]  S. J. Graham,et al.  Quantitative correlation of breast tissue parameters using magnetic resonance and X-ray mammography. , 1996, British Journal of Cancer.

[7]  David M. Haaland,et al.  Partial least-squares methods for spectral analyses. 2. Application to simulated and glass spectral data , 1988 .

[8]  Alessandro Torricelli,et al.  Effects of the Menstrual Cycle on the Red and Near-infrared Optical Properties of the Human Breast¶ , 2000, Photochemistry and photobiology.

[9]  Lothar Lilge,et al.  Classification of breast tissue density by optical transillumination spectroscopy: optical and physiological effects governing predictive value. , 2004 .

[10]  R. Warren.  Hormones and mammographic breast density. , 2004, Maturitas.

[11]  N F Boyd,et al.  Mammographic densities and breast cancer risk. , 1998, Breast disease.

[12]  J. Wolfe.  Breast patterns as an index of risk for developing breast cancer. , 1976, AJR. American journal of roentgenology.

[13]  R L Egan,et al.  Optical Spectroscopy , 1988, Acta radiologica.

[14]  A. Miller,et al.  Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. , 1995, Journal of the National Cancer Institute.

[15]  N. Boyd,et al.  Effects at two years of a low-fat, high-carbohydrate diet on radiologic features of the breast: results from a randomized trial. Canadian Diet and Breast Cancer Prevention Study Group. , 1997, Journal of the National Cancer Institute.

[16]  O. Konez,et al.  Can tamoxifen cause a significant mammographic density change in breast parenchyma? , 2001, Clinical imaging.

[17]  H. Thornton.  Anastrozole as a preventive agent in breast cancer , 2003, The Lancet.

[18]  T. Julian,et al.  Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers. , 2001, Cytometry.

[19]  N F Boyd,et al.  Ultrasonographically defined parenchymal patterns of the breast: relationship to mammographic patterns and other risk factors for breast cancer. , 1988, The British journal of radiology.

[20]  M S Patterson,et al.  Optical properties of normal and diseased human breast tissues in the visible and near infrared. , 1990, Physics in medicine and biology.

[21]  J. Wolfe.  Risk for breast cancer development determined by mammographic parenchymal pattern , 1976, Cancer.

[22]  Stephen W Duffy,et al.  Tamoxifen and breast density in women at increased risk of breast cancer. , 2004, Journal of the National Cancer Institute.

[23]  E White,et al.  Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. , 1998, Journal of the National Cancer Institute.

[24]  Karla Kerlikowske,et al.  Mammographic breast density and family history of breast cancer. , 2003, Journal of the National Cancer Institute.

[25]  M. Dowsett,et al.  Effects of the aromatase inhibitor letrozole on normal breast epithelial cell proliferation and metabolic indices in postmenopausal women: a pilot study for breast cancer prevention. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[26]  Lothar Lilge,et al.  Non-ionizing near-infrared radiation transillumination spectroscopy for breast tissue density and assessment of breast cancer risk. , 2004, Journal of biomedical optics.

[27]  R N Hoover,et al.  Mammographic densities and risk of breast cancer , 1991, Cancer.

[28]  E. V. Thomas,et al.  Partial least-squares methods for spectral analyses. 1. Relation to other quantitative calibration methods and the extraction of qualitative information , 1988 .

[29]  J. Samet,et al.  Associations of weight, weight change, and body mass with breast cancer risk in Hispanic and non-Hispanic white women. , 2002, Annals of epidemiology.

[30]  N. Boyd,et al.  Automated analysis of mammographic densities. , 1996, Physics in medicine and biology.

[31]  L. Hilakivi-Clarke.  Estrogens, BRCA1, and breast cancer. , 2000, Cancer research.